Commercial Syn Bags Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 16.1%)
Concerns
- Trading near 52-week high (₹315)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| HAL Hindustan Aeronautics Limited | ₹4,856 | ₹3.2L Cr | 34.8 | 7.91 | 24 | 32 | 0 |
| BEL Bharat Electronics Limited | ₹405 | ₹3.0L Cr | 48.2 | 12.36 | 27.4 | 36.4 | 0 |
| TMCV Tata Motors Limited | ₹475 −0.03% | ₹1.7L Cr | 22.7 | 10.71 | 34 | 35.9 | 0.44 |
| ABB ABB India Limited | ₹7,410 | ₹1.6L Cr | 102 | 16.8 | 22.4 | 29.9 | 0.02 |
| BHEL Bharat Heavy Electricals Limited | ₹431 | ₹1.5L Cr | 61.7 | 5.74 | 6.23 | 9.14 | 0.45 |
| SIEMENS Siemens Limited | ₹3,977 | ₹1.4L Cr | 94.2 | 10.22 | 19.2 | 21.4 | 0.01 |
| CGPOWER CG Power and Industrial Solutions Limited | ₹891 | ₹1.4L Cr | 110 | 17.61 | 20.5 | 26.7 | 0.02 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
COMSYN · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 58.79% | 58.79% | 58.79% | 58.79% | 58.79% | 58.79% |
| FII | — | 0.11% | — | — | — | — |
| Public | 41.22% | 41.10% | 41.21% | 41.22% | 41.22% | 41.21% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
Dividend - Re 0.40 Per Share
Annual General Meeting
Latest News
All newsTata Motors unit makes voluntary tender offer for Iveco Group
*Tata Motors unit makes voluntary tender offer for Iveco Group.* TML CV Holdings B.V., an indirect wholly-owned subsidiary of Tata Motors, has launched a voluntary tender offer for **all shares** of Iveco Group N.V. The move signals a major strategic expansion in the commercial vehicle sector. Financial terms were not disclosed. 📊 *STOCKS:* $TATAMOTORS | 🏢 *SECTOR:* Corporate | #HIGHIMPACT #Acquisition
Welspun Investments reports board meeting outcome.
*Welspun Investments reports board meeting outcome.* The board met on September 01, 2026, to consider and approve certain business matters. No major financials or strategic decisions were disclosed. The outcome did not include any **₹500Cr**+ transaction or leadership change. 📊 *STOCKS:* $WICL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Wabag appoints Rohan Mittal as Chief Commercial & Development Officer MEA
*Wabag appoints Rohan Mittal as Chief Commercial & Development Officer MEA*. This is a strategic leadership role focused on Middle East and Africa (MEA) operations. The change reflects internal restructuring without immediate financial implications. No financial figures or operational shifts were disclosed. 📊 *STOCKS:* $WABAG | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #LeadershipChange
Morepen reports record Q1 revenue, EBITDA up 207%, PAT up 394%
*Morepen reports record Q1 revenue, EBITDA up 207%, PAT up 394%*. The company posted its highest-ever quarterly revenue and earnings in Q1 FY27. EBITDA surged by **207%** while PAT jumped **394%** year-on-year. Its CDMO segment has entered full-scale commercialization, marking a key growth milestone. 📊 *STOCKS:* $MOREPENLAB | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Biocon launches Yesafili, a U.S. biosimilar to Eylea® 2 mg
*Biocon launches Yesafili, a U.S. biosimilar to Eylea® 2 mg* — Biocon has announced the U.S. commercial launch of Yesafili, a biosimilar to Regeneron’s Eylea® 2 mg. The launch marks a **major expansion** into the U.S. ophthalmology market, targeting **$4 billion** in annual sales. This move strengthens Biocon’s global footprint and potential revenue streams. 📊 *STOCKS:* $BIOCON | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Biosimilar
SML Isuzu to acquire M&M’s Truck and Bus division
*SML Isuzu to acquire Mahindra & Mahindra’s Truck and Bus Division via slump sale.* The acquisition is structured under a Business Transfer Agreement, marking a strategic expansion in the commercial vehicle space. This move significantly enhances SML Isuzu’s product portfolio and manufacturing capabilities. The transaction value and terms will be disclosed in upcoming filings. 📊 *STOCKS:* $SMLISUZU | 🏢 *SECTOR:* Auto | #HIGHIMPACT #Acquisition
JSW Steel completes merger of ARCL, MCL, JRDL
*JSW Steel completes merger of ARCL, MCL, JRDL* — JSW Steel announced the receipt of the final NCLT order for the amalgamation of Amalgamated Rural Commercial Limited (ARCL), Maheshwari Commercial Limited (MCL), and JRDBL with itself. The merger is expected to streamline operations and enhance corporate efficiency. No financial terms were disclosed. 📊 *STOCKS:* JSWSTEEL | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Merger
Tata Motors clears Italian regulatory hurdle for Iveco acquisition
*Tata Motors clears Italian regulatory hurdle for Iveco acquisition.* The Italian regulator has approved the offer document, advancing Tata Motors' acquisition of Iveco. The deal strengthens Tata’s global commercial vehicle footprint. **No financial terms disclosed**, but strategic implications are significant. 📊 *STOCKS:* $TATAMOTORS | 🏢 *SECTOR:* Auto | #HIGHIMPACT #Acquisition
Brookfield India REIT to buy Godrej BKC for ₹17,000 crore
*Brookfield India REIT approves ₹17,000 crore acquisition of Godrej BKC.* This is one of the largest real estate deals in India, signaling strong institutional interest in premium commercial assets. The transaction could impact Godrej Industries’ valuation and future strategy. 📊 *STOCKS:* $GODREJIND | 🏢 *SECTOR:* Realty | #HIGHIMPACT #REIT
RBI mandates greater lender transparency for borrowers
*RBI mandates greater lender transparency for borrowers.* The central bank requires all lenders to disclose detailed loan terms, interest calculations, and hidden charges upfront. This move aims to protect retail borrowers and increase accountability in credit disbursal. The rule applies to all scheduled commercial banks and NBFCs. 📊 *STOCKS:* | 🏢 *SECTOR:* Regulation | #HIGHIMPACT #RBI
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹97.48 Cr 1.0% | ₹98.45 Cr 8.8% | ₹90.51 Cr 7.4% | ₹97.79 Cr 13.1% | ₹86.49 Cr 0.2% | ₹86.65 Cr 12.7% | ₹76.89 Cr 10.4% | ₹69.63 Cr |
| Op. Profit | ₹12.09 Cr 7.0% | ₹13 Cr 18.0% | ₹11.02 Cr 3.2% | ₹11.38 Cr 20.4% | ₹9.45 Cr 20.2% | ₹7.86 Cr 14.4% | ₹6.87 Cr 21.4% | ₹8.74 Cr |
| OPM | 12.4% 6.1% | 13.2% 8.4% | 12.2% 4.6% | 11.6% 6.5% | 10.9% 20.5% | 9.1% 1.6% | 8.9% 28.8% | 12.6% |
| Net Profit | ₹6 Cr 28.7% | ₹8.42 Cr 51.7% | ₹5.55 Cr 31.2% | ₹8.07 Cr 129.3% | ₹3.52 Cr 2.2% | ₹3.6 Cr 86.5% | ₹1.93 Cr 40.1% | ₹3.22 Cr |
| EPS (₹) | 1.5 28.9% | 2.11 51.8% | 1.39 31.2% | 2.02 129.5% | 0.88 2.2% | 0.9 87.5% | 0.48 40.7% | 0.81 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹347 Cr 20.5% | ₹288 Cr 0.7% | ₹290 Cr 10.2% | ₹323 Cr 51.6% | ₹213 Cr 11.5% | ₹191 Cr |
| Expenses | ₹312 Cr 19.5% | ₹261 Cr 1.9% | ₹266 Cr 8.0% | ₹289 Cr 52.9% | ₹189 Cr 13.2% | ₹167 Cr |
| Op. Profit | ₹36 Cr 33.3% | ₹27 Cr 12.5% | ₹24 Cr 29.4% | ₹34 Cr 36.0% | ₹25 Cr 4.2% | ₹24 Cr |
| OPM | 10.0% 11.1% | 9.0% 12.5% | 8.0% 20.0% | 10.0% 16.7% | 12.0% 0.0% | 12.0% |
| Other Income | ₹4 Cr 33.3% | ₹3 Cr 50.0% | ₹2 Cr 50.0% | ₹4 Cr 300.0% | ₹1 Cr 50.0% | ₹2 Cr |
| Interest | ₹9 Cr 12.5% | ₹8 Cr 33.3% | ₹6 Cr 14.3% | ₹7 Cr 75.0% | ₹4 Cr 0.0% | ₹4 Cr |
| Depreciation | ₹9 Cr 18.2% | ₹11 Cr 10.0% | ₹10 Cr 11.1% | ₹9 Cr 12.5% | ₹8 Cr 14.3% | ₹7 Cr |
| PBT | ₹21 Cr 90.9% | ₹11 Cr 22.2% | ₹9 Cr 57.1% | ₹21 Cr 40.0% | ₹15 Cr 7.1% | ₹14 Cr |
| Tax % | 20.0% 25.9% | 27.0% 92.9% | 14.0% 0.0% | 14.0% 17.6% | 17.0% 19.0% | 21.0% |
| Net Profit | ₹17 Cr 112.5% | ₹8 Cr 0.0% | ₹8 Cr 55.6% | ₹18 Cr 50.0% | ₹12 Cr 9.1% | ₹11 Cr |
| EPS (₹) | 4.29 117.8% | 1.97 2.5% | 2.02 58.9% | 4.92 46.0% | 3.37 4.7% | 3.22 |
| Div Payout | 9.0% | 0.0% | 0.0% 100.0% | 14.0% 30.0% | 20.0% 25.0% | 16.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
Liabilities | |||||||
| Equity Capital | ₹40 Cr 0.0% | ₹40 Cr 0.0% | ₹40 Cr 0.0% | ₹40 Cr 233.3% | ₹12 Cr 0.0% | ₹12 Cr 0.0% | ₹12 Cr |
| Reserves | ₹122 Cr 10.9% | ₹110 Cr 23.6% | ₹89 Cr 9.9% | ₹81 Cr 12.9% | ₹93 Cr 38.8% | ₹67 Cr 17.5% | ₹57 Cr |
| Borrowings | ₹109 Cr 5.2% | ₹115 Cr 5.5% | ₹109 Cr 43.4% | ₹76 Cr 9.5% | ₹84 Cr 2.3% | ₹86 Cr 65.4% | ₹52 Cr |
| Other Liabilities | ₹44 Cr 2.3% | ₹43 Cr 19.4% | ₹36 Cr 16.1% | ₹31 Cr 3.1% | ₹32 Cr 0.0% | ₹32 Cr 68.4% | ₹19 Cr |
| Total Liabilities | ₹316 Cr 2.6% | ₹308 Cr 12.8% | ₹273 Cr 20.3% | ₹227 Cr 2.3% | ₹222 Cr 12.7% | ₹197 Cr 40.7% | ₹140 Cr |
Assets | |||||||
| Fixed Assets | ₹102 Cr 2.0% | ₹100 Cr 7.4% | ₹108 Cr 9.1% | ₹99 Cr 5.3% | ₹94 Cr 8.0% | ₹87 Cr 50.0% | ₹58 Cr |
| CWIP | ₹4 Cr 100.0% | ₹2 Cr | ₹0 Cr 100.0% | ₹13 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹14 Cr |
| Investments | ₹24 Cr 4.3% | ₹23 Cr 4.5% | ₹22 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹185 Cr 1.1% | ₹183 Cr 28.0% | ₹143 Cr 23.3% | ₹116 Cr 9.4% | ₹128 Cr 17.4% | ₹109 Cr 60.3% | ₹68 Cr |
| Total Assets | ₹316 Cr 2.6% | ₹308 Cr 12.8% | ₹273 Cr 20.3% | ₹227 Cr 2.3% | ₹222 Cr 12.7% | ₹197 Cr 40.7% | ₹140 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Operating CF | ₹1 Cr 83.3% | ₹6 Cr 84.2% | ₹38 Cr 533.3% | ₹6 Cr 166.7% | ₹-9 Cr 133.3% | ₹27 Cr |
| Investing CF | ₹0 Cr 100.0% | ₹-29 Cr 3.3% | ₹-30 Cr 328.6% | ₹-7 Cr 58.8% | ₹-17 Cr 0.0% | ₹-17 Cr |
| Financing CF | ₹0 Cr 100.0% | ₹23 Cr 387.5% | ₹-8 Cr 700.0% | ₹-1 Cr 103.6% | ₹28 Cr 380.0% | ₹-10 Cr |
| Net Cash Flow | ₹1 Cr | ₹0 Cr 100.0% | ₹-1 Cr 50.0% | ₹-2 Cr 200.0% | ₹2 Cr | ₹0 Cr |
| Free Cash Flow | ₹-1 Cr | ₹0 Cr 100.0% | ₹10 Cr 211.1% | ₹-9 Cr 66.7% | ₹-27 Cr 370.0% | ₹10 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Debtor Days | 49d 9.3% | 54d 54.3% | 35d 12.5% | 40d 8.1% | 37d 5.7% | 35d |
| Inventory Days | 160d 2.4% | 164d 27.1% | 129d 12.2% | 115d 39.5% | 190d 72.7% | 110d |
| Days Payable | 37d 5.1% | 39d 14.7% | 34d 13.3% | 30d 18.9% | 37d 76.2% | 21d |
| Cash Conv. Cycle | 172d 3.9% | 179d 37.7% | 130d 4.0% | 125d 34.2% | 190d 53.2% | 124d |
| Working Capital Days | 40d 42.9% | 28d 36.4% | 44d 4.8% | 42d 20.0% | 35d 0.0% | 35d |
| ROCE | 12.0% 33.3% | 9.0% 12.5% | 8.0% 50.0% | 16.0% 23.1% | 13.0% | — |
Source: Screener.in · Lower days = better efficiency
About Commercial Syn Bags Limited
Incorporated in 1984, Commercial Syn Bags Ltd manufactuers and exports containers and packaging materials[1]
Capital GoodsIndustrial Products